Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancer
about
Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcoma.Prostate cancer health disparities: An immuno-biological perspective.Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation.Bioactive Compounds from Posidonia oceanica (L.) Delile Impair Malignant Cell Migration through Autophagy Modulation.Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways.Recent Advances in Prostate Cancer Treatment and Drug Discovery.Attenuation of everolimus-induced cytotoxicity by a protective autophagic pathway involving ERK activation in renal cell carcinoma cells.PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data.Cisplatin-induced ERK1/2 activity promotes G1 to S phase progression which leads to chemoresistance of ovarian cancer cells.Scutellarin induces apoptosis and autophagy in NSCLC cells through ERK1/2 and AKT Signaling Pathways in vitro and in vivo
P2860
Q43991475-F5482C6B-1E17-45EB-86F4-6A909DD2D3AFQ46537204-32D61DA3-7EB9-4244-AD1A-14A51A8E5C6AQ47404758-CF199801-E07D-4029-8DE9-3973FA445679Q52566065-63AC0262-C8FF-4DF5-A210-7D7CD3EA3821Q52682335-51C03001-3FBD-4AFB-8803-ECA4255652E5Q54111821-2066BDB7-D3F4-4F48-A30C-D0CF74A7FFA0Q54112994-31B31BD6-6303-4857-BD13-C25ABBE223EDQ55017642-F18E13E4-1287-403F-B4BE-94C29638AB2DQ55122746-CC53701D-4813-4B64-8DF6-75BB550125CDQ57116844-FB81D52A-AC3F-4D0E-8C17-31F8AD87AAFE
P2860
Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancer
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Inhibition of the PI3K/AKT/mTO ...... signalling in prostate cancer
@en
type
label
Inhibition of the PI3K/AKT/mTO ...... signalling in prostate cancer
@en
prefLabel
Inhibition of the PI3K/AKT/mTO ...... signalling in prostate cancer
@en
P2093
P2860
P356
P1433
P1476
Inhibition of the PI3K/AKT/mTO ...... signalling in prostate cancer
@en
P2093
Barry R Davies
Christopher Marlein
Dominika E Butler
Hannah F Walker
Matthew S Simms
Norman J Maitland
Vincent M Mann
P2860
P304
56698-56713
P356
10.18632/ONCOTARGET.18082
P407
P577
2017-05-23T00:00:00Z